Overall Technical outlook

Price Summary

NATCO Pharma Limited had a phenomenal day at the stock market, and its shares skyrocketed 5.47%.
On 2025-12-11, NATCOPHARM's stock opened at 870.0, reached a peak of 933.65, dropped to 865.9, and ended 5.47% higher at 917.55, with a volume of 6399004 shares.
During the 52-week span, the stock hit a high of 1476.8 and a low of 746.5.
The future price of NATCOPHARM is anticipated to range from 725.0 to 1480.0, with an expected mean price of 985.1727, according to the recommendations of 11 analysts.

Technicals

Support and Resistance: At 917.55, the price is held up by support at 884.45 and faces resistance at 973.6 for NATCOPHARM. This suggests a trading range where 884.45 provides a base and 973.6 limits upward movement.
NATCOPHARM supportResistance a33ee7
Support/Resistance for NATCOPHARM


Aroon: The current state of the AROON is neutral for NATCOPHARM, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
NATCOPHARM aroon a33ee7
Aroon chart for NATCO Pharma Limited


Bol. Bands: The BOLL BANDS is showing a neutral stance, with no definitive indication of an upward or downward trend for NATCOPHARM. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
NATCOPHARM bbands a33ee7
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR for NATCOPHARM remains bearish, establishing a key resistance level that could hinder upward movement. This ongoing bearish outlook suggests that the market may face challenges in breaking higher, with the resistance level acting as a barrier to potential gains.
NATCOPHARM psar a33ee7
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The current reading of the STOCHASTIC indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
NATCOPHARM stoch a33ee7
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
NATCOPHARM trippleSMA a33ee7
Tripple SMA chart for NATCO Pharma Limited


Understanding a company's fundamentals—such as revenue, earnings, and debt levels—provides a solid foundation for analyzing its technical performance. Similarly, knowledge of the industry, including key competitors and market trends, is critical. Combining this fundamental analysis with technical indicators like stock charts, moving averages, and trading volume enables a more comprehensive approach to evaluating the company's overall health and potential future performance.